BRCA Reversion Mutations in Metastatic Castration-Resistant Prostate Cancer

被引:3
|
作者
Vandekerkhove, Gillian [1 ,2 ,3 ]
机构
[1] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[2] BC Canc, Dept Med Oncol, Vancouver, BC, Canada
[3] Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H3Z6, Canada
关键词
D O I
10.1016/j.eururo.2022.09.031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:210 / 211
页数:2
相关论文
共 50 条
  • [1] Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib
    Loehr, Andrea
    Hussain, Arif
    Patnaik, Akash
    Bryce, Alan H.
    Castellano, Daniel
    Font, Albert
    Shapiro, Jeremy
    Zhang, Jingsong
    Sautois, Brieuc
    Vogelzang, Nicholas J.
    Chatta, Gurkamal
    Courtney, Kevin
    Harzstark, Andrea
    Ricci, Francesco
    Despain, Darrin
    Watkins, Simon
    King, Charmin
    Nguyen, Minh
    Simmons, Andrew D.
    Chowdhury, Simon
    Abida, Wassim
    EUROPEAN UROLOGY, 2023, 83 (03) : 200 - 209
  • [2] High prevalence and heterogeneity of emergence of BRCA reversion mutations at progression on niraparib treatment in BRCA-mutant metastatic castration-resistant prostate cancer (mCRPC) patients
    Urtishak, Karen
    Attard, Gerhardt
    Kanno, Tokuwa
    Thomas, Shibu
    Mason, Gary E.
    Espina, Byron
    Zhu, Eugene
    Hutnick, Natalie
    Guckert, Mary
    del Corrals, Adam
    Li, Mark
    Lopez-Gitlitz, Angela
    Chi, Kim
    Kelly, William Kevin
    Yu, Evan Y.
    Fizazi, Karim
    Smith, Matthew
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [4] BRCA mutation and castration-resistant prostate cancer
    Spirina, L. V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation
    Saillant, Arnaud
    Flippot, Ronan
    BULLETIN DU CANCER, 2021, 108 (02) : 140 - 142
  • [6] Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer
    Alessandra Modena
    Roberto Iacovelli
    Aldo Scarpa
    Matteo Brunelli
    Chiara Ciccarese
    Emanuela Fantinel
    Davide Bimbatti
    Francesco Massari
    Guido Martignoni
    Giampaolo Tortora
    Targeted Oncology, 2016, 11 : 569 - 577
  • [7] Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer
    Modena, Alessandra
    Iacovelli, Roberto
    Scarpa, Aldo
    Brunelli, Matteo
    Ciccarese, Chiara
    Fantinel, Emanuela
    Bimbatti, Davide
    Massari, Francesco
    Martignoni, Guido
    Tortora, Giampaolo
    TARGETED ONCOLOGY, 2016, 11 (05) : 569 - 577
  • [8] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Smith, Thomas J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1175 - 1175
  • [9] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [10] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70